Developing a Highly Sensitive Urine Test for Bladder Cancer

Bladder cancer is one of the major cancers of the urinary system that is one of the most expensive cancers to treat due to a high recurrence rate.

Typically, routine monitoring of bladder cancer is performed by cystoscopic examination and is invasive, painful, and expensive. Cystoscopy is often augmented by a non-invasive laboratory method such as urine cytology. However, these tests lack adequate sensitivity or specificity to significantly improve the diagnosis and treatment of bladder cancer patients.


We constantly update this page with the latest publications.  If you still can’t find what you’re looking for, need more information about URO17 please feel free to get in touch with us – we will be more than happy to help.

We need your consent to load the translations

We use a third-party service to translate the website content that may collect data about your activity. Please review the details and accept the service to view the translations.